TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Lung Cancer · Lung Cancer Metastatic · Lung Cancer, Non-small Cell · Lung Cancer Recurrent
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
District One Hospital, Beijing, Beijing Municipality, China